ArticleMaterials today. Bio2025
Vascularized in vitro bone model as 3D quadruple culture with primary human osteoblasts, osteocytes, osteoclasts and endothelial cells.
Article in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Advancing Biomaterials Evaluation: A Human Quadruple Bone Cell Culture Reveals Molybdenum-Driven Pro-Osteogenic and Anti-osteoclastogenic Responses.ACS applied materials & interfaces · 2026Article
- siRNA Delivery via Cross-Linked Gelatin Microparticles Enables Targeted Modulation of Osteogenic-Vascular Cross-Talk: An Advanced Human 3D in Vitro Test System for Therapeutic siRNA.Advanced healthcare materials · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
With an aging population worldwide, research into bone metabolism and novel therapies for damaged and diseased bone is essential. Bone is a vascularized, dynamic tissue that undergoes a constant remodeling process mediated by osteocytes, osteoblasts and osteoclasts. In this study, a complex 3D in vitro bone model combining these three main bone cell species with endothelial cells was developed. The different cell species were isolated from primary human tissue and spatially arranged using transwell inserts. Osteocytes differentiated from collagen-embedded osteoblasts, while osteoclasts simultaneously derived from peripheral blood mononuclear cells without receptor activator of NF-κB ligand (RANKL) supplementation. Different cultivation parameters were evaluated to define conditions that support differentiation and function of all cell types involved in quadruple culture. The cellular crosstalk in quadruple cultures stimulated osteoblast (ALP, BMP-2, IBSP, COL1A, VEGF) and osteocyte (SOST, DMP1) markers, while osteoclast (TRAP) and endothelial cell markers were reduced compared to respective mono- or co-cultures. Furthermore, mineralization was induced only in quadruple cultures, demonstrating the importance of signaling between the four cell types. This sophisticated human bone model provides a physiologically relevant culture system to study the complex crosstalk between bone cells, their precursors and endothelial cells during remodeling and vascularization. Moreover, it allows preclinical testing of bioactive factors, biomaterial extracts or drugs for translation into clinical practice without animal testing.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.